Cervical, Vaginal and Vulval Inflammatory Diseases

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cervical, Vaginal and Vulval Inflammatory Diseases trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT04211103

Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions

single arm phase II trial evaluating Pembrolizumab single agent as neoadjuvant treatment before surgical conization and/or partial or radical vulvectomy in pati…

Italy45 participantsStarted 2020-10-14

Treatment: Pembrolizumab